-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, L/jPfqm9Jld65V7XueE+2+4LXwyGvFQzlw36etr6klLRBrgm/fAADCB6mFT7OS47 DAJLLlpWqN818pWJpwZxGA== 0000898430-96-000925.txt : 19960325 0000898430-96-000925.hdr.sgml : 19960325 ACCESSION NUMBER: 0000898430-96-000925 CONFORMED SUBMISSION TYPE: 8-B12B/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960322 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: MYCOGEN CORP CENTRAL INDEX KEY: 0000813742 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE SERVICES [0700] IRS NUMBER: 953802654 STATE OF INCORPORATION: CA FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 8-B12B/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-11643 FILM NUMBER: 96537638 BUSINESS ADDRESS: STREET 1: 5501 OBERLIN DR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6194538030 MAIL ADDRESS: STREET 1: 5501 OBERLIN DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 8-B12B/A 1 FORM 8-B12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-B/A FOR REGISTRATION OF SECURITIES OF CERTAIN SUCCESSOR ISSUERS Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 Mycogen Corporation ------------------- (Exact name of registrant as specified in its charter) California 0-15881 95-3802654 ---------- ------- ---------- (State or other jurisdiction (Commission File Number) (IRS Employer of incorporation) Identification No.) 5501 Oberlin Drive, San Diego California, 92121 ----------------------------------------------- (Address of principal executive offices) Registrant's telephone number, including area code: 619-453-8030 Not Applicable -------------- (Former name or former address, if changed since last report.) SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(B) OF THE ACT: TITLE OF EACH CLASS NAME OF EACH EXCHANGE ON WHICH TO BE SO REGISTERED EACH CLASS IS TO BE REGISTERED -------------------- ------------------------------- NONE - ------------------------------ ------------------------------- - ------------------------------ ------------------------------- SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT: PREFERRED SHARE PURCHASE RIGHTS ------------------------------- (Title of Class) 1 ITEMS 1. - 6. Items 1 through 6 from the Form 8-B filed by the Registrant on February 13, 1996, are hereby incorporated by this reference. All provisions of the Rights Agreement as defined in such Form 8-B remain the same except that Amendment No. 1 to Amended and Restated Rights Agreement, dated February 20, 1996, deleted all references in the Rights Agreement to the Lubrizol Corporation. ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS (a) Not applicable. (b) Not applicable. (c) Exhibits: The following Exhibit is filed as part of this Form 8-B: --------- Exhibit Number Description -------------- ----------- 4.1 Amendment No. 1 to Amended and Restated Rights Agreement/1/ /1/ Previously filed as an exhibit to the Company's Form 8-K filed on March 22, 1996, and incorporated herein by reference. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Mycogen Corporation ------------------- (Registrant) Date: March 22, 1996, /s/ James A. Baumker --------------- ---------------------- James A. Baumker Vice President, Chief Financial Officer, Chief Accounting Officer 2 -----END PRIVACY-ENHANCED MESSAGE-----